SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,000 | +54.3% | 12,477 | +109.3% | 0.00% | – |
| Q1 2023 | $221,000 | -16.0% | 5,962 | -17.6% | 0.00% | -100.0% |
| Q4 2022 | $263,000 | -78.4% | 7,232 | -85.9% | 0.00% | -85.7% |
| Q2 2020 | $1,217,000 | +499.5% | 51,379 | +1173.3% | 0.01% | +600.0% |
| Q3 2018 | $203,000 | -19.4% | 4,035 | -4.5% | 0.00% | -50.0% |
| Q2 2018 | $252,000 | -45.7% | 4,225 | -77.5% | 0.00% | -60.0% |
| Q3 2016 | $464,000 | +51.6% | 18,761 | -7.2% | 0.01% | +400.0% |
| Q1 2016 | $306,000 | +3.7% | 20,207 | -6.8% | 0.00% | -75.0% |
| Q4 2015 | $295,000 | – | 21,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |